These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33609949)

  • 21. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
    Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
    Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.
    Wang PP; Song X; Zhao XK; Wei MX; Gao SG; Zhou FY; Han XN; Xu RH; Wang R; Fan ZM; Ren JL; Li XM; Wang XZ; Yang MM; Hu JF; Zhong K; Lei LL; Li LY; Chen Y; Chen YJ; Ji JJ; Yang YZ; Li J; Wang LD
    Front Oncol; 2022; 12():790933. PubMed ID: 35155234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
    BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
    Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
    J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.
    Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I
    World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Di S; Li M; Ma Z; Guo K; Li X; Yan X
    Pathol Res Pract; 2019 Jun; 215(6):152415. PubMed ID: 31064720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
    Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
    Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma.
    Luo LL; Zhao L; Xi M; He LR; Shen JX; Li QQ; Liu SL; Zhang P; Xie D; Liu MZ
    Chin J Cancer; 2015 Sep; 34(11):514-21. PubMed ID: 26370590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raman spectroscopy and machine learning for the classification of esophageal squamous carcinoma.
    Huang W; Shang Q; Xiao X; Zhang H; Gu Y; Yang L; Shi G; Yang Y; Hu Y; Yuan Y; Ji A; Chen L
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121654. PubMed ID: 35878494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
    He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
    Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
    Che J; Zhao Y; Gu B; Li S; Li Y; Pan K; Sun T; Han X; Lv J; Zhang S; Fan B; Li C; Wang C; Wang J; Zhang T
    BMC Cancer; 2023 Dec; 23(1):1238. PubMed ID: 38102546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase D1 mRNA level may predict cancer-specific survival in heavy smokers with esophageal squamous cell cancers.
    Xie X; Zhang SS; Wen J; Yang H; Luo KJ; Yang F; Hu Y; Fu JH
    Dis Esophagus; 2014; 27(2):188-95. PubMed ID: 23621299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
    Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM
    Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
    Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
    Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.